Clinical Trials in Houston

Showing 2161-2180 of 8,625 trials

Ultrasound Evaluation for Baxter VASCU-GUARD Vascular Patches Post-Endarterectomy and Complications Assessment

NCT07048067

VASCU-GUARD vascular patches with the new packaging have been available at the Houston Methodist Hospital since January 2023. This study is a retrospective chart review, aiming to compare the performance of Baxter VASCU-GUARD vascular patches implemented during carotid endarterectomies (CEA) prior to January 2023 and after January 2023. This study is one of a kind, as no other comparative retrospective chart review on the performance of VASCU-GUARD vascular patches from the old and new packaging has been published yet. The project will contribute to the scientific knowledge about long-term outcomes associated with the use of patch material during endarterectomies.

Carotid Endarterectomy (CEA) Surgical Patients

The Methodist Hospital Research Institute500 participantsStarted Jan 2023

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

NCT05568706

This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult subjects with confirmed RSV infection who are at high risk for complications after RSV infection.

RSV Infection

Enanta Pharmaceuticals, Inc186 participantsStarted Nov 2022

Tempe, Arizona, United States • Fresno, California, United States • Lomita, California, United States +81 more locations

Ultrasound Evaluation for Baxter VASCU-GUARD Vascular Patches Post-Endarterectomy and Complications Assessment

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Find Trials by Condition in Houston

Modifying a Telephone Based Care Program to Assess for Self-Neglect

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

Vaginal Ecosystem and Network in the United States Study

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

Cough Reduction in IPF With Nalbuphine ER